Andi,
I have been interested in immunotherapy for some time. There was a lot of work done on it for bc in the 80's, which was abandoned when the leading proponent of it retired. I think it is something that deserves to be pursued, and I am gratified when I see an article like the one I posted here. Of course, I am particularly thrilled that the work is being done in Her2+ patients.
Hopeful